Palatin Technologies (PTN) Change in Account Payables (2010 - 2026)
Palatin Technologies' (PTN) quarterly Change in Account Payables came in at -$8558.0 in Q1 2026, down 100.81% YoY from $1.1 million in Q1 2025, and up 99.56% on a QoQ basis from -$2.0 million in Q4 2025.
Palatin Technologies (PTN) Change in Account Payables (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has 17 years of Change in Account Payables data on file, last reported at -$8558.0 in Q1 2026.
- Quarterly Change in Account Payables fell 100.81% year-over-year to -$8558.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 153.75% YoY) and the FY2025 annual result came in at $2.9 million, up 1536.96% from the prior year.
- Change in Account Payables rose to -$8558.0 in Q1 2026, from -$2.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.8 million in Q4 2024 to a low of -$3.1 million in Q4 2022.
- A 5-year average of $311980.2 and a median of $658682.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 822.29% in 2022, down 407.2% in 2022.
- Tracing PTN's Change in Account Payables over 5 years: stood at -$3.1 million in 2022, then soared by 77.88% to -$676164.0 in 2023, then surged by 509.55% to $2.8 million in 2024, then sank by 170.52% to -$2.0 million in 2025, then soared by 99.56% to -$8558.0 in 2026.
- The last three Change in Account Payables figures came in at -$8558.0 (Q1 2026), -$2.0 million (Q4 2025), and $407043.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | -8,558.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,558.00 |
| Mar 31, 2026 | -8,558.00 |
| Dec 31, 2025 | -1.95 Mn |
| Dec 31, 2025 | -1.95 Mn |
| Sep 30, 2025 | 407,043.00 |
| Sep 30, 2025 | 407,043.00 |
| Jun 30, 2025 | -771,761.00 |
| Jun 30, 2025 | -771,761.00 |
| Mar 31, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | -152,901.00 |
| Sep 30, 2024 | -152,901.00 |
| Jun 30, 2024 | 658,682.00 |
| Jun 30, 2024 | 658,682.00 |
| Mar 31, 2024 | 1.85 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | -676,164.00 |
| Dec 31, 2023 | -676,164.00 |